USES AND TREATMENTS with Elixio Cannabis extracts

​

Migraines & Headaches, Hepatitis, Oxidative Stress, Anorexia & Cachexia, Arthritis, Pain, Chronic pain, Nausea and vomiting, Sleep Apena, Insomnia, Spinal injury, Fatigue, Asthma, Hypertension, improve reproductive system, Body tempeture(Fever), Strengthen the immune system, Inflamation, Phantom Limb, Fibromialgya, Bipolar disorder, PTSD, Sores, Canker sores

Elixio oils >10:1, 4:1, 3:1, 2:1 ratios (thc/cbd) hybrids 50/50 or sativa-dominant strains
ELIXIO, ELIXIO Forte, ELIXIO Capsules, ELIXIO Life Series

​

​

 

Cancer
Some cannabinoids such as THC, CBD, CBG, CBN and THCV among others, help to inhibit the action of the ID protein, responsible for determining the highest degree of aggressiveness and the possibility of tumor metastasis.
Therefore, the endocannabinoid system exerts a set of effects on growth, progression, angiogenesis and migration of tumor cells.
Various clinical trials also highlight the effectiveness of cannabinoids as an alternative therapy or palliative for symptoms during chemotherapy, especially for nausea, vomiting, loss of appetite,
physical pain, depression, gastrointestinal and skin problems.
- 82 detailed studies and explained with video and illustrations, on the efficiency of marijuana against cancer
- Cristina Sánchez: Cannabinoids as Anti-Tumor Therapy
- More than 1300 scientific studies related to Cancer and Cannabinoids in Pubmed.

Elixio Lab suggestion = >10:1 4:1, 3:1 ratios (thc/cbd) hybrids 50/50 or sativa-dominant strains
ELIXIO, ELIXIO Forte, ELIXIO Life Series, ELIXIO Capsules, Elixio Cream

 

​

​

Epilepsy
The medicinal qualities of cannabis not only help to alleviate the disease, but also have a
neuroprotective effect thanks to its anti-inflammatory properties. There are other cannabinoids such as CBDV and THCV that would also have antiepileptic effects, however long-term studies are lacking that endorse its function.
- More than 300 scientific studies related to Epilepsy and Cannabinoids in Pubmed

Elixio Lab suggestion = 3:1, 2:1 ratio (thc/cbd) hybrids 50/50 or indica-dominant strains

ELIXIO,  ELIXIO Neuro, ELIXIO CBD

​

​

Depression
Traditional medicine treatments for these disorders generally produce side effects associated with selective serotonin and norepinephrine reuptake inhibitors. These effects often bring more problems to patients since in many cases they feelmore depressed.
Cannabinoids are considered to be the only drug capable of promoting neurogenesis in the
hippocampus after chronic administration. Having an effect, directly associated, between the
increased neurogenesis and anxiolytic-antidepressant effects of patients.
- More than 440 scientific studies related to Depression and Cannabinoids in Pubmed.
Elixio Lab suggest = >10:1, 4:1, 3:1, 2:1 ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains

ELIXIO, ELIXIO Forte, ELIXIO CBD, ELIXIO Capsules, ELIXIO Life Series
 

​

 

Multiple Sclerosis
Although MS has been considered primarily an inflammatory disorder, recent evidence has
manifested the importance of neurodegenerative events, opening the possibility that
Cannabinoids, given their cytoprotective properties, can also serve to reduce the death of
oligodendrocytes and axonal damage during disease.
- More than 450 scientific studies related to Multiple Sclerosis and Cannabinoids in Pubmed.
Elixio Lab suggest = 2:1, 1:1 ratio (thc/cbd) hybrids 50/50 or indica-dominant strains
ELIXIO Neuro, ELIXIO CBD

 

 

 

Parkinson's
The current treatment used in traditional medicine can produce side effects such as:
Dementia, depression and cognitive decline. However, clinical trials have shown the effectiveness
of cannabinoids as a treatment for parkinson's without causing disorders that result from
traditional medication where their findings point to improve quality of life through the use of
CBD without psychiatric effects.
Cannabinoids have therapeutic value in some movement-related disorders thanks to
reduction of dyskinesia, some forms of L-DOPA-induced tremor and dystonia in the
Parkinson's disease, and could contribute to the decrease of tics in Tourette syndrome and
hypokinetic parkinsonian syndromes.
- More than 50 scientific studies related to Parkinson's and Cannabinoids in Pubmed.
Elixio Lab suggest = 2:1, 1:1 ratio (thc/cbd) hybrids 50/50 or indica-dominant strains

ELIXIO, ELIXIO Neuro, ELIXIO CBD, ELIXIO Life Series

​

​

​

Diabetes Mellitus Neuropathy
is the most common complication of diabetes and is still considered to be relatively
refractory to most pain relievers.
Cannabis treatment significantly relieves abnormal sensation of mechanical pain (allodynia) and
restores the perception of thermal pain without affecting hyperglycemia. CBD increases the content of reduced glutathione (GSH) in the liver, leading to a restoration of the defense mechanism and decreases peroxidation of liver lipids, suggesting that CBD provides protection against oxidative damage in diabetes.
- More than 120 scientific studies related to Diabetes Melitus and Cannabinoids in Pubmed.

Elixio Lab suggest = >10:1, 4:1, 3:1, 2:1 ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains
ELIXIO, ELIXIO Forte, ELIXIO Life Series

​

​

HIV / AIDS
The analgesic effect that cannabinoids have significantly helps people who suffer joint pain at the nervous and muscular level as a consequence of HIV. In addition, treatments with Cannabinoids have shown positive effects with respect to increased fat levels in patients suffering from loss of appetite. Another effect is relief against nausea, one of the most common symptoms among people with HIV.
Social pressure, rejection or side effects caused by the drugs used in the
antiretroviral treatments often lead to depressive states, anxiety and changes
in the mood. However, patients consuming medicinal cannabis increased their levels of
self-esteem, feelings of friendship and empathy.

Elixio Lab suggest = >10:1, 4:1, 3:1 ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains

ELIXIO, ELIXIO Forte, ELIXIO Life Series, ELIXIO Capsules

​

​

Alzheimer's
Recent studies on therapeutic strategies for neurodegenerative diseases such as
Parkinson's and Alzheimer's have focused on neuroprotective properties (for example, retarding
neurodegeneration in progress) anti-inflammatory and antioxidant of cannabinoids, considering it, not only as a palliative treatment of symptoms, but as a therapeutic approach for this group of
diseases, thus delaying symptoms of the disease such as dementia.
At the molecular level, THC has been studied to inhibit the enzyme Acetylcholinesterase (AchE), as well as it also prevents the aggregation of the marker (Aβ), key in the disease, by binding in place peripheral anion. In this way, THC would be a much more powerful inhibitor than drugs.
currently used for the treatment of AZ, thus preventing its progression.
- More than 70 scientific studies related to Alzheimer and Cannabinoids in Pubmed.

Elixio Lab suggest = 3:1, 2:1 ratio (thc/cbd) hybrids 50/50 or indica-dominant strains

ELIXIO, ELIXIO Life Series, ELIXIO Neuro, ELIXIO CBD

​

​

​

​

Crohn's Disease
Clinical trials have shown that the intestine contains elevated levels of cannabinoids (CB1, CBD2), and that is why both THC and CBD are used for treatment of the disease, reducing symptoms and improving metabolic processes, is for this reason, that patients who decide to use cannabinoids for the treatment of Crohn, have decreased their traditional medication drastically due to symptomatic improvements.
Cannabinoids play an important role in the action they have on gastrointestinal motility and
its antidiarrheal effect. Another point to consider is related to the feeling of well-being that could
produce the Cannabinoids due to their central action.

Elixio Lab suggest = Elixio 4:1, 3:1, 2:1 ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains

ELIXIO, ELIXIO Forte, ELIXIO Life Series

​

​

​

Psoriasis
Mast cells are cells that regulate inflammatory processes by releasing interleukins, histamines, proteases, TNF among others. Because of this, studies have evaluated the effectiveness ofCB1R cannabinoid receptors to inhibit inflammation mediators without causing toxicity in cells. CB1R has been found to be a strong mast cell agonist and topical application of this agonist, suppresses the recruitment of mast cells in the skin, thus reducing the level of histamine in blood. This would be very favorable to alleviate the symptoms caused by diseases inflammatory skin diseases such as psoriasis, among others.
In addition to the above, and because cannabinoid receptors are widely distributed on the skin, and having already assumed that cannabinoids (CB) have potent anti-inflammatory properties, it has been also seen the importance that it could have in the regulation of the hyperproliferation of keratinocytes in skin (characteristic present in psoriasis), thus supporting the role that CB could have in psoriasis treatment
- 9 scientific studies related to Psoriasis and Cannabinoids in Pubmed.

Elixio Lab suggest = Elixio Cream and Elixio Oil 4:1, 3:1 ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains

ELIXIO, ELIXIO Life Series, ELIXIO Cream

​

​

​

Glaucoma
Cannabinoids could be used effectively in topical therapies for diseases neurodegenerative diseases of the retina, either alone or as a combination treatment with other drugs with the aim of improving sight in millions of people suffering from diseases such as glaucoma.
The peripheral vasodilator property of cannabis has been verified. By inhaling this substance, it was seen that in a time of between 60 to 90 min in subjects with glaucoma, the effects appeared hypotensive, reducing both intraocular pressure and blood pressure.
Because of this, some specialists suggest that cannabis could be the ideal drug for glaucoma treatment, since in their experimental studies, they have shown to have a good tolerance after topical application, it would be effective in reducing intraocular pressure and also for its neuroprotective behavior on retinal ganglion cells.
- More than 70 scientific studies related to Glaucoma and Cannabinoids in Pubmed

Elixio Lab suggest = Elixio >10:1, 4:1, 3:1, ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains

ELIXIO, ELIXIO Forte, ELIXIO Capsules, ELIXIO Life Series

​

​

​

​

Autoimmune Disease
Cannabinoids have shown their presence in almost all our body thanks to the receptors cannabinoids (CB-1 and CB-2). CB-1 receptors have been found in both the brain, lungs, muscles, reproductive organs, hypothalamus, cerebellum, hippocampus, amygdala, spinal cord, gastrointestinal tract, vascular system, among others. CB-2 receptors have been found in the spleen, bones, skin and glial cells. Furthermore, both CB-1 and CB-2 receptors have been found both in the immune system, as in liver, bone marrow, pancreas and the encephalic trunk.
The influence of cannabinoids on immune function has been widely examined in last 25 years. Studies suggest that cannabinoids modulate the function of T and B lymphocytes, as well as NK cells and macrophages.
These substances have also been documented to modulate host resistance, especially secondary immune response, to various infectious agents (Herpes simplex virus, retroviruses, staphylococcus, Listeria, Treponema and Legionella). Finally, several tests, with in vivo and in in vitro models, has determined that cannabinoids modulate the production and function of acute phase cytokines, and modulate the activity of cells like macrophages and Thelper, Th1 and Th2.
- More than 100 scientific studies related to autoimmune diseases, systemic inflammation and
Cannabinoids at Pubmed.

Elixio Lab suggest = Elixio >10:1, 4:1, 3:1, 2/1 ratio (thc/cbd) hybrids 50/50 or sativa-dominant strains

ELIXIO, ELIXIO Forte, ELIXIO Capsules, ELIXIO Life Series

​

​

​

​

Psychiatric Symptoms 
Cannabidiol (CBD) significantly reduces psychopathological disorders thanks to its effects
Antipsychotics, and unlike common medicine, have fewer adverse effects. Because of this, many
Schizophrenia patients use it to alleviate the side effects of common therapy with neuroleptics, as well as parkinsonian symptoms.
Recent studies on therapeutic strategies for neurodegenerative diseases have been focused on neuroprotective properties (eg retarding ongoing neurodegeneration) anti-inflammatory and antioxidant of cannabinoids, considering it this way, not only as a treatmentpalliative of symptoms, but as a therapeutic approach, delaying symptoms such as dementia.

Elixio Lab suggest = Elixio oils 2:1, 1:1 ratio (thc/cbd) hybrids 50/50 or indica-dominant strains

ELIXIO, ELIXIO Neuro, ELIXIO CBD, ELIXIO Life Series

​

​

​

 

Autism
Research has highlighted the effectiveness of medicinal cannabis in treating autism because improves behavior and communication skills. And it has been discovered that there is a connection between autism and cannabinoid receptors, such as cannabinoid 2 (CB2) receptors and the endocannabinoid system.
There are currently no means to prevent autism, nor are there fully effective treatments. In In this sense, medicinal cannabis to treat autism may be an alternative to reduce or alleviate some typical symptoms of this disease, as supported by the aforementioned studies
previously.
- In 2016 a study was carried out with a 6-year-old boy diagnosed with this condition. Thank you This report showed that medical cannabis for treating autism was effective. During 6 months, the boy carried out a treatment with THC and managed to improve his condition in aspects such as hyperactivity, lethargy, irritability, stereotypes or inappropriate speech.
Although autism is considered the most complex and varied when diagnosing and recommending the indicated strain. The key, too, is to have a medium and long-term consistency with the progressive use of cannabis. Cannabis microdoses (oils / drops) are ideal for treating autism. Consistency, the environment, food and stimulation go hand in hand. Without them it is very difficult to notice noticeable improvements or changes in the short term.
- 5 scientific studies related to Autism and Cannabinoids in Pubmed.

Elixio Lab suggest = Elixio oils 2:1, 1:1 ratio (thc/cbd) hybrids 50/50 

ELIXIO Neuro, ELIXIO CBD

​

​

Other pathologies which are addressed with Cannabinoids:

Endometriosis, Syndrome Tourette, Spasticity, Seizures, Angelman Syndrome, Withdrawal Syndrome,
Elixio oils 4:1. 3:1, 2:1, 1:1 ratio (thc/cbd) hybrids 50/50 or indica-dominant strains

ELIXIO, ELIXIO Neuro, ELIXIO CBD, ELIXIO Life Series